Cepharanthine protects against lipopolysaccharide-induced acute lung injury in mice by blocking NLRP3 inflammasome activation

Key Points

• Cepharanthine significantly reduces acute lung injury, indicating its protective effects.
• The treatment effectively blocks NLRP3 inflammasome activation, a key inflammatory pathway.
• Observational analysis in mice after lipopolysaccharide exposure shows significant inflammation reduction.
• These findings suggest a potential therapeutic pathway for treating lung injuries, pending further studies.